Dembrexine

This classification denotes a mucolytic agent with the molecular formula C13H17Br2NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4F61F502T5, chemically known as 4,6-dibromo-alpha-(trans-4-hydroxycyclohexylamino)-o-cresol but generally known as dembrexine, which bears US NIH Compound Identifier 72009. European Medicines Agency schedules Dembrexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06961MIG. The term DEMBREXINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). DEMBREXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dembrexine under HS 29225000 and SITC 51467. As of Q4 2014, DEMBREXINE remains the US FDA Preferred Term for this commodity. Dembrexine bears US NLM identifiers UMLS ID C0057360 and NCI Concept Code C78114. SMILES: Brc1c(O)c(CNC2CCC(O)CC2)cc(Br)c1.